Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Previous issues

Page Path
HOME > Browse articles > Previous issues
10 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 42(2); June 2010
Prev issue Next issue
Review Article
Geriatric Oncology: An Overview of Progresses and Challenges
Martine Extermann
Cancer Res Treat. 2010;42(2):61-68.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.61
AbstractAbstract PDFPubReaderePub

Thanks to the global improvement of health care and living conditions, the world population is aging. Already, in developed countries half of the cancers occur in patients aged 70 and older. In booming Asian nations, such as South Korea, the aging trend is particularly striking, and therefore geriatric oncology is rapidly coming at the foreground of oncology practice. As older patients have a very variable health status, the need for proper integration of an oncologic and a geriatric approach has become increasingly clear. The last two decades have seen the development of geriatric oncology programs and research, which we review here. An increasing amount of data is making clear that a geriatric assessment identifies many problems in older people with cancer, adds prognostic information, and might improve the outcomes of these patients. The near future will likely deliver the following: Operationalization of geriatric assessment into assessment and decision tools, as well as multidisciplinary interventions, in oncology; cooperation of aging and cancer research in the understanding of cancer biology, aging physiology, pharmacology of anticancer drugs; improved clinical study designs; development of geriatric oncology programs, and screening tools accessible to the private practitioner.

Citations

Citations to this article as recorded by  
  • Development of geriatric oncology in Latin America: A report from the Latin American Cooperative Oncology Group
    Luciola Pontes Leite de Barros, Ludmila de Oliveira Muniz Koch, Jurema Telles de Oliveira Lima, Thiago Lourenço Apolinario, Aldo Lourenco Abbade Dettino, Cristiane Rios Petrarca, Janine Capobiango Martins, Polianna Mara Rodrigues de Souza, Morgani Rodrigu
    Journal of Geriatric Oncology.2024; 15(3): 101642.     CrossRef
  • Psychoonkologische Interventionen bei geriatrischen Tumorpatienten
    E. Jentschke, Tamina Jacobi
    Die MKG-Chirurgie.2024; 17(3): 182.     CrossRef
  • Cancer in the older Indian population: Understanding the current context in an emerging economy
    Suzanne Nethan, Meena Cherian, Etienne Brain, Atreyi Ganguli, Fikru Tullu, Najia Musolino, Roopa Hariprasad, Richard Sullivan, Ravi Mehrotra
    Journal of Geriatric Oncology.2022; 13(3): 273.     CrossRef
  • Points de vue d’usagers sur la déprescription de médicaments en maison de retraite
    Lucie Lechevalier Hurard, Damien Cateau, Olivier Bugnon, Anne Niquille Charrière, Rose-Anna Foley
    Gérontologie et société.2020; vol. 42 / (1): 171.     CrossRef
  • Polypharmacy, limited activity, fatigue and insomnia are the most frequent symptoms and impairments in older hematological cancer survivors (70+): Findings from a register-based study on physical and mental health
    Heide Götze, Norbert Köhler, Sabine Taubenheim, Florian Lordick, Anja Mehnert
    Journal of Geriatric Oncology.2019; 10(1): 55.     CrossRef
  • Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10
    Dirk L. Kienle, Daniel Dietrich, Karin Ribi, Andreas Wicki, Luca Quagliata, Ralph C. Winterhalder, Dieter Koeberle, Daniel Horber, Sara Bastian, Marc Kueng, Piercarlo Saletti, Daniel Helbling, Daniela Baertschi, Alessandro Lugli, Juerg Bernhard, Christian
    Journal of Geriatric Oncology.2019; 10(2): 304.     CrossRef
  • Geriatric Assessment, Not ASA Physical Status, Is Associated With 6-Month Postoperative Survival in Patients With Cancer Aged ≥75 Years
    Armin Shahrokni, Bella Marie Vishnevsky, Brian Jang, Saman Sarraf, Koshy Alexander, Soo Jung Kim, Robert Downey, Anoushka Afonso, Beatriz Korc-Grodzicki
    Journal of the National Comprehensive Cancer Network.2019; 17(6): 687.     CrossRef
  • Performance of the Multidimensional Geriatric Assessment and Multidimensional Prognostic Index in predicting negative outcomes in older adults with cancer
    V. Giantin, C. Falci, E. De Luca, E. Valentini, M. Iasevoli, P. Siviero, S. Maggi, B. Martella, G. Crepaldi, S. Monfardini, E. Manzato
    European Journal of Cancer Care.2018; 27(1): e12585.     CrossRef
  • Ältere Patienten (70+) in der Onkologie
    Heide Götze, Anja Mehnert
    best practice onkologie.2018; 13(2): 80.     CrossRef
  • The impact of age on complications, survival, and cause of death following colon cancer surgery
    Christopher T Aquina, Supriya G Mohile, Mohamedtaki A Tejani, Adan Z Becerra, Zhaomin Xu, Bradley J Hensley, Reza Arsalani-Zadeh, Francis P Boscoe, Maria J Schymura, Katia Noyes, John RT Monson, Fergal J Fleming
    British Journal of Cancer.2017; 116(3): 389.     CrossRef
  • Therapeutic efficacy of combined PEGylated liposomal doxorubicin and radiofrequency ablation: Comparing single and combined therapy in young and old mice
    Alexander V. Andriyanov, Emma Portnoy, Erez Koren, Semenenko Inesa, Sara Eyal, S. Nahum Goldberg, Yechezkel Barenholz
    Journal of Controlled Release.2017; 257: 2.     CrossRef
  • Comprehensive Geriatric Assessment and Caring for the Older Person with Cancer
    Janine Overcash, Mary Alice Momeyer
    Seminars in Oncology Nursing.2017; 33(4): 440.     CrossRef
  • Grassroots inter-professional networks: the case of organizing care for older cancer patients
    Fatou Farima Bagayogo, Annick Lepage, Jean-Louis Denis, Lise Lamothe, Liette Lapointe, Isabelle Vedel
    Journal of Health Organization and Management.2016; 30(6): 971.     CrossRef
  • Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301)
    Gaetan Des Guetz, Thierry Landre, Virginie Westeel, Bernard Milleron, Fabien Vaylet, Thierry Urban, Fabrice Barlesi, Pierre-Jean Souquet, Didier Debieuvre, Denis Braun, Gislaine Fraboulet, Isabelle Monnet, Bernard Uzzan, Olivier Molinier, Franck Morin, De
    Journal of Geriatric Oncology.2015; 6(3): 233.     CrossRef
  • Challenges in Cancer Care of Elderly
    Virender Suhag, B. S. Sunita, Arti Sarin, A. K. Singh
    International Journal of Medical Physics, Clinical Engineering and Radiation Oncology.2015; 04(01): 25.     CrossRef
  • Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review
    M.T.E. Puts, H.A. Tu, A. Tourangeau, D. Howell, M. Fitch, E. Springall, S.M.H. Alibhai
    Annals of Oncology.2014; 25(3): 564.     CrossRef
  • Is It Helpful to Give Older People with Cancer the Same Chance at Rehabilitation as Older General Medical Patients?
    C. Lethborg, R. Brown, S. Posenelli, L. Pollerd, S. Wigg, C. Challis, A. Hocking, C. Whitehall
    Journal of Psychosocial Oncology.2014; 32(4): 396.     CrossRef
  • Les fonctions cognitives au commencement d’une nouvelle ligne de traitement chez des patients âgés atteints d’un cancer hématologique
    B. Jonius, Y. Libert, I. Bragard, C. Reynaert, D. Razavi, A. -M. Étienne
    Psycho-Oncologie.2013; 7(2): 118.     CrossRef
  • Adjuvant Pharmacotherapy in the Management of Elderly Patients with Pancreatic Cancer
    Raphaël Maréchal, Anne Demols, Jean-Luc Van Laethem
    Drugs & Aging.2013; 30(3): 155.     CrossRef
  • Epidemiology of prostate cancer in the Asia-Pacific region
    Peter D. Baade, Danny R. Youlden, Susanna M. Cramb, Jeff Dunn, Robert A. Gardiner
    Prostate International.2013; 1(2): 47.     CrossRef
  • Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival
    Ming Y. Lim, Elisabeth K. Stephens, Paul Novotny, Katharine Price, Marcia Salayi, Lindsey Roeker, Prema Peethambaram, Aminah Jatoi
    Journal of Geriatric Oncology.2013; 4(3): 249.     CrossRef
  • Systemic Treatment of Gastrointestinal Cancer in Elderly Patients
    Silvana Leo, Caterina Accettura, Antonio Gnoni, Antonella Licchetta, Marianna Giampaglia, Annamaria Mauro, Valeria Saracino, Brian I. Carr
    Journal of Gastrointestinal Cancer.2013; 44(1): 22.     CrossRef
  • Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?
    L. Biganzoli, L. Boni, D. Becheri, E. Zafarana, C. Biagioni, S. Cappadona, E. Bianchini, C. Oakman, S.U. Magnolfi, A. Di Leo, G. Mottino
    Annals of Oncology.2013; 24(2): 494.     CrossRef
  • Influence of age on the pharmacokinetics of i.v. vinflunine: Results of a phase I trial in elderly cancer patients
    J.M. Tourani, L. Mourey, V. Servent, T. Nguyen, A. Ravaud, V. Girre, S. Favrel, M.C. Pinel, N. Isambert
    Journal of Geriatric Oncology.2012; 3(1): 41.     CrossRef
  • Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients
    Joo Ho Lee, Hong-Gyun Wu, Hak Jae Kim, Dong-Wan Kim, Se-Hoon Lee, Tae Min Kim, Young Whan Kim, Dae Seog Heo
    Cancer Research and Treatment.2012; 44(4): 242.     CrossRef
  • Enhancing life after cancer in diverse communities
    Judith S. Kaur, Kathryn Coe, Julia Rowland, Kathryn L. Braun, Francisco A. Conde, Linda Burhansstipanov, Sue Heiney, Marjorie Kagawa‐Singer, Qian Lu, Catherine Witte
    Cancer.2012; 118(21): 5366.     CrossRef
  • Therapeutic options in older patients with metastatic non-small cell lung cancer
    Elisabeth Quoix
    Therapeutic Advances in Medical Oncology.2012; 4(5): 247.     CrossRef
  • Advanced non-small cell lung cancer in elderly patients
    Elisabeth Quoix
    Breathe.2012; 9(1): 26.     CrossRef
  • Évaluation des sujets âgés avant traitement
    E. Quoix
    Revue des Maladies Respiratoires Actualités.2011; 3(4): 285.     CrossRef
  • Optimal Pharmacotherapeutic Strategies for Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Elisabeth Quoix
    Drugs & Aging.2011; 28(11): 885.     CrossRef
  • Anticancer Drug Use in Geriatric Patients: Concerns and Challenges
    Denys T. Lau, Mary H. Jarzebowski, June M. McKoy
    Clinical Therapeutics.2011; 33(10): 1408.     CrossRef
  • Prevention of Neutropenia-Related Events in Elderly Patients with Hematological Cancer
    Jean Klastersky, Andrea Gombos, Aspasia Georgala, Ahmad Awada
    Aging Health.2011; 7(6): 829.     CrossRef
  • Prostate cancer: an emerging threat to the health of aging men in Asia
    Ling Zhang, Bao-Xue Yang, Hai-Tao Zhang, Jin-Guo Wang, Hong-Liang Wang, Xue-Jian Zhao
    Asian Journal of Andrology.2011; 13(4): 574.     CrossRef
  • Systemic Therapy for Elderly Patients with Gastrointestinal Cancer
    Joleen M. Hubbard, Axel Grothey, Daniel J. Sargent
    Clinical Medicine Insights: Oncology.2011;[Epub]     CrossRef
  • Major clinical research advances in gynecologic cancer in 2010
    Dong Hoon Suh, Jae Weon Kim, Kidong Kim, Soon-Beom Kang
    Journal of Gynecologic Oncology.2010; 21(4): 209.     CrossRef
  • 11,440 View
  • 96 Download
  • 35 Crossref
Close layer
Original Articles
Clinicopathologic Characteristics, Surgical Treatment and Outcomes for Splenic Flexure Colon Cancer
Chan Wook Kim, Ui Sup Shin, Chang Sik Yu, Jin Cheon Kim
Cancer Res Treat. 2010;42(2):69-76.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.69
AbstractAbstract PDFPubReaderePub
Purpose

This current study examined the clinicopathologic characteristics of patients with splenic flexure (SF) colon cancer and the association with the surgical outcomes to find the optimal procedure to treat this malady.

Materials and Methods

A total of 167 operated patients with SF colon cancer were consecutively recruited between 1993 and 2003. The clinicopathological, operative and survival data was reviewed and analyzed.

Results

For the SF colon cancer patients, the proportion of males was higher than that for the right-sided colon patients or the sigmoid-descending junction & sigmoid (SD & S) colon patients (p≤0.05, respectively) and the age at the time of diagnosis was younger (p≤0.05). Obstruction was more frequent in the patients with SF colon cancer than that for the patients with colon cancer at other sites (p≤0.001). The incidence of mucinous adenocarcinoma for the SF patients was similar to that for the patients with right-sided colon cancer, but it was higher than that for the patients with SD & S colon cancer (11.4% vs. 6.5%, p=0.248 or 2.5%, respectively, p=0.001). Disease-free and overall survival did not differ between the patients who underwent a left hemicolectomy and extended surgery such as combined splenectomy or subtotal colectomy. Multivariate analysis showed that old age (≥60 years) and a N1-2 and M1 status were the independent risk factors for overall survival.

Conclusion

The SF colon cancers exhibited exclusively different characteristics as compared to colon cancers at other site colon cancers. It appears that left hemicolectomy was generally sufficient for a satisfactory oncological outcome, obviating concurrent splenectomy.

Citations

Citations to this article as recorded by  
  • Surgical approach to splenic flexure adenocarcinoma of the colon: Less is more?
    Julia Kohn, Julia Frebault, Qi Wang, Sonja Boatman, Alexander Troester, Christine Jensen, Schelomo Marmor, Wolfgang B. Gaertner, Imran Hassan, Paolo Goffredo
    Surgical Oncology Insight.2024; 1(2): 100039.     CrossRef
  • Laparoscopic extended right colectomy with complete mesocolic excision and en bloc splenectomy for a distal transverse colon cancer—A video vignette
    Javier Vela, Christophe Riquoir, Juan Alvarado, Nicolás Besser, José Tomás Larach
    Colorectal Disease.2024; 26(7): 1485.     CrossRef
  • Extended procedure has no oncological benefits over segmental resection in the treatment of non-metastatic splenic flexure colon cancer, a population-based cohort study and a single center’s decade-long experience
    Xiaojie Wang, Yangyang Wang, Zhifang Zheng, Zhiping Chen, Zhongdong Xie, Xingrong Lu, Shenghui Huang, Ying Huang, Pan Chi
    Updates in Surgery.2024; 76(4): 1289.     CrossRef
  • Splenic flexure adenocarcinoma: A national cohort analysis of extent of surgical resection and outcomes
    Julia F. Kohn, Sonja Boatman, Qi Wang, Schelomo Marmor, Imran Hassan, Robert D. Madoff, Wolfgang B. Gaertner, Paolo Goffredo
    Colorectal Disease.2024; 26(11): 1883.     CrossRef
  • Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN)
    Maurizio Degiuli, Monica Ortenzi, Mariano Tomatis, Lucia Puca, Desiree Cianflocca, Daniela Rega, Annalisa Maroli, Ugo Elmore, Francesca Pecchini, Marco Milone, Roberta La Mendola, Erica Soligo, Simona Deidda, Domenico Spoletini, Diletta Cassini, Alessandr
    Surgical Endoscopy.2023; 37(2): 977.     CrossRef
  • Short and long-term oncologic outcomes of patients with colon cancer of the splenic flexure
    Chi Zhang, Esteban Calderon, Yu Hui Chang, Ga-ram Han, Scott R. Kelley, Amit Merchea, Justin T. Brady, Tonia M. Young-Fadok, David A. Etzioni, Nitin Mishra
    The American Journal of Surgery.2023; 226(1): 77.     CrossRef
  • Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision (CME) and central vascular ligation (CVL)
    Krishanth Naidu, Pierre H. Chapuis, Kilian G. M. Brown, Charles Chan, Matthew J. F. X. Rickard, Kheng‐Seong Ng
    ANZ Journal of Surgery.2023; 93(7-8): 1861.     CrossRef
  • The impact of laparoscopic, open, extended right, and left colectomy on clinical outcomes of splenic flexure colon cancer: A meta-analysis
    Hefei Cheng, Minjian Zhou, Lianlei Yang, Ziqi Sui
    Medicine.2023; 102(19): e33742.     CrossRef
  • Standardization of the Definition and Surgical Management of the Splenic Flexure Carcinoma by an International Expert Consensus Using the Delphi Technique: Room for Improvement?
    Cigdem Benlice, Amjad Parvaiz, Bilgi Baca, Werner Hohenberger, Danilo Miskovic, Luca Stocchi, Scott Steele, Seon-Hahn Kim, Torbjörn Holm, Antonino Spinelli, Ismail Gogenur, Yves Panis, Hirotoshi Hasegawa, Alexey Karachun, Juan C Patron Uriburu, Masaki Ito
    Diseases of the Colon & Rectum.2023;[Epub]     CrossRef
  • Laparoscopic complete mesocolic excision with central vascular ligation for splenic flexure colon cancer: short- and long-term outcomes
    Kazuki Ueda, Koji Daito, Hokuto Ushijima, Yoshinori Yane, Yasumasa Yoshioka, Tadao Tokoro, Masayoshi Iwamoto, Toshiaki Wada, Yusuke Makutani, Junichiro Kawamura
    Surgical Endoscopy.2022; 36(4): 2661.     CrossRef
  • Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort
    Corrado Pedrazzani, Giulia Turri, Soo Yeun Park, Koya Hida, Yudai Fukui, Jacopo Crippa, Giovanni Ferrari, Matteo Origi, Gaya Spolverato, Matteo Zuin, Sung Uk Bae, Seong Kyu Baek, Andrea Costanzi, Dario Maggioni, Gyung Mo Son, Andrea Scala, Timothy Rockall
    Colorectal Disease.2022; 24(2): 177.     CrossRef
  • Emergency surgery for obstructive splenic flexure colon cancer: results of a multicentric study of the French Surgical Association (AFC)
    Camélia Labiad, Gilles Manceau, Diane Mege, Antoine Cazelles, Thibault Voron, Valérie Bridoux, Zaher Lakkis, Solafah Abdalla, Mehdi Karoui, Aurélien Venara, Mehdi Ouaissi, Charles Sabbagh, Tatiana Codjia, Marie Dazza, Guillaume Gagnat, Servane Hamel, Laur
    Updates in Surgery.2022; 74(1): 107.     CrossRef
  • What Is the Optimal Elective Colectomy for Splenic Flexure Cancer: End of the Debate? A Multicenter Study From the GRECCAR Group With a Propensity Score Analysis
    Gilles Manceau, Arnaud Alves, Hélène Meillat, Léonor Benhaïm, Mehdi Ouaïssi, Yves H. Panis, Jean-Jacques Tuech, Bertrand Dousset, Cécile Brigand, Eddy Cotte, Zaher Lakkis, Bogdan Badic, Frédéric Marchal, Charles Sabbagh, Momar Diouf, Mehdi Karoui
    Diseases of the Colon & Rectum.2022; 65(1): 55.     CrossRef
  • Segmental resection of splenic flexure colon cancers provides an adequate lymph node harvest and is a safe operative approach – an analysis of the ACS-NSQIP database
    Allison J. Pang, Daniel Marinescu, Nancy Morin, Carol-Ann Vasilevsky, Marylise Boutros
    Surgical Endoscopy.2022; 36(8): 5652.     CrossRef
  • A Comparison between Different Management Surgical Approaches in the Treatment of Splenic Flexure Colon Cancer
    Elsayed I. El-Hendawy, Mohamed Farouk Amin, Ahmed M. Fahmy, Ahmed Z. Alattar, Shereen Elshorbagy, Ola A. Harb, Ahmed Fathy Gomaa, Ahmed Embaby, Ahmed M. Elsayed, Gamal Osman, Ramadan M. Ali
    Journal of Coloproctology.2022; 42(01): 047.     CrossRef
  • Comparison of laparoscopic and open colectomy for splenic flexure colon cancer: a systematic review and meta-analysis
    Jini Wu, Bo Li, Shiliang Tu, Boan Zheng, Bingchen Chen
    International Journal of Colorectal Disease.2022; 37(4): 757.     CrossRef
  • Surgical Treatment of SplenicFlexure Colon Cancer: Analysisof Short-Term and Long-Term Outcomes of Three DifferentSurgical Procedures
    Mingjin Huang, Xiaojie Wang, Yu Shao, Shenghui Huang, Ying Huang, Pan Chi
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Extended right colectomy, left colectomy, or segmental left colectomy for splenic flexure carcinomas: a European multicenter propensity score matching analysis
    Nicola de’Angelis, Aleix Martínez-Pérez, Des C. Winter, Filippo Landi, Giulio Cesare Vitali, Bertrand Le Roy, Federico Coccolini, Francesco Brunetti, Valerio Celentano, Salomone Di Saverio, Frederic Ris, David Fuks, Eloy Espin
    Surgical Endoscopy.2021; 35(2): 661.     CrossRef
  • Segmental versus extended colectomy for tumours of the transverse colon: a systematic review and meta‐analysis
    Stefan Morarasu, Cillian Clancy, Catherine T Cronin, Takeru Matsuda, Helen M Heneghan, Desmond C Winter
    Colorectal Disease.2021; 23(3): 625.     CrossRef
  • Laparoscopic Colectomy for Splenic Flexure Cancer Approached from Four Directions
    Hiroki Hashida, Masato Kondo, Ryosuke Kita, Koji Kitamura, Kenji Uryuhara, Hiroyuki Kobayashi, Satoshi Kaihara
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2021; 31(9): 1014.     CrossRef
  • Bowel function recovery after laparoscopic transverse colectomy within an ERAS program: a comparison to right and left colectomy
    Raffaello Roesel, Francesco Mongelli, Costanza Ajani, Fabiano Iaquinandi, Diana Celio, Dimitri Christoforidis
    Langenbeck's Archives of Surgery.2021; 406(5): 1563.     CrossRef
  • Emergency surgery for splenic flexure cancer: results of the SFC Study Group database
    Nicola de’Angelis, Eloy Espin, Frederic Ris, Filippo Landi, Bertrand Le Roy, Federico Coccolini, Valerio Celentano, Angela Gurrado, Denis Pezet, Giorgio Bianchi, Riccardo Memeo, Giulio C. Vitali, Alejandro Solis, Christine Denet, Salomone Di Saverio, Gian
    World Journal of Emergency Surgery.2021;[Epub]     CrossRef
  • Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis
    Jiefeng Zhao, Jinfeng Zhu, Rui Sun, Chao Huang, Rongfa Yuan, Zhengming Zhu
    BMC Cancer.2021;[Epub]     CrossRef
  • Short- and long-term outcomes of laparoscopic segmental left colectomy for splenic flexure colon cancer: comparison with propensity score matching
    Moon Jin Kim, Ji Hoon Kim, Yoon Suk Lee, Bong Hyeon Kye, Hyeon Min Cho, Hyung Jin Kim, Won Kyung Kang
    Annals of Surgical Treatment and Research.2021; 101(5): 274.     CrossRef
  • Surgical treatment of a colon neoplasm of the splenic flexure: a multicentric study of short‐term outcomes
    G. A. Binda, A. Amato, G. Alberton, M. Bruzzone, P. Secondo, J. Lòpez‐Borao, R. Giudicissi, A. Falato, C. Fucini, F. Bianco, S. Biondo
    Colorectal Disease.2020; 22(2): 146.     CrossRef
  • Laparoscopic resection with complete mesocolic excision for splenic flexure cancer: long-term follow-up data from a multicenter retrospective study
    Umberto Bracale, Giovanni Merola, Giusto Pignata, Francesco Corcione, Felice Pirozzi, Diego Cuccurullo, Giovanni Domenico De Palma, Elisa Cassinotti, Antonio Sciuto, Luigi Boni
    Surgical Endoscopy.2020; 34(7): 2954.     CrossRef
  • Elective surgery for tumours of the splenic flexure: a French inter-group (AFC, SFCD, FRENCH, GRECCAR) survey
    G. Manceau, S. Benoist, Y. Panis, A. Rault, M. Mathonnet, D. Goere, J. J. Tuech, D. Collet, C. Penna, M. Karoui
    Techniques in Coloproctology.2020; 24(2): 191.     CrossRef
  • Laparoscopic segmental left colectomy for splenic flexure carcinoma: a single institution experience
    Q. Chenevas-Paule, B. Trilling, P. Y. Sage, E. Girard, J. L. Faucheron
    Techniques in Coloproctology.2020; 24(1): 41.     CrossRef
  • Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study
    M. Milone, M. Degiuli, M.E. Allaix, C.A. Ammirati, G. Anania, A. Barberis, A. Belli, P.P. Bianchi, F. Bianco, C. Bombardini, M. Burati, D. Cavaliere, C. Coco, A. Coratti, R. De Luca, G. De Manzoni, P. De Nardi, M. De Rosa, P. Delrio, A. Di Cataldo, A. Di
    European Journal of Surgical Oncology.2020; 46(9): 1683.     CrossRef
  • Which is more important in the management of splenic flexure colon cancer: strict central lymph node dissection or adequate bowel resection margin?
    Y. Yamaoka, A. Shiomi, H. Kagawa, H. Hino, S. Manabe, S. Kato, M. Hanaoka
    Techniques in Coloproctology.2020; 24(8): 873.     CrossRef
  • Laparoscopic left hemicolectomy with regional lymph node navigation and intracorporeal anastomosis for splenic flexure colon cancer
    Yoshiro Itatani, Kenji Kawada, Koya Hida, Yasunori Deguchi, Nobu Oshima, Rei Mizuno, Toshiaki Wada, Tomoaki Okada, Yoshiharu Sakai
    International Cancer Conference Journal.2020; 9(4): 170.     CrossRef
  • Comparison of extended right hemicolectomy, left hemicolectomy and segmental colectomy for splenic flexure colon cancer: a systematic review and meta‐analysis
    S. Hajibandeh, S. Hajibandeh, I. Hussain, A. Zubairu, F. Akbar, A. Maw
    Colorectal Disease.2020; 22(12): 1885.     CrossRef
  • Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology–Colorectal Cancer Network Collaborative Group
    Maurizio Degiuli, Rossella Reddavid, Fulvio Ricceri, Francesca Di Candido, Monica Ortenzi, Ugo Elmore, Claudio Belluco, Riccardo Rosati, Marco Guerrieri, Antonino Spinelli
    Diseases of the Colon & Rectum.2020; 63(10): 1372.     CrossRef
  • Clinical–Pathologic Characteristics and Long-term Outcomes of Left Flexure Colonic Cancer: A Retrospective Analysis of an International Multicenter Cohort
    Corrado Pedrazzani, Giulia Turri, Soo Yeun Park, Koya Hida, Yudai Fukui, Jacopo Crippa, Giovanni Ferrari, Matteo Origi, Gaya Spolverato, Matteo Zuin, Sung Uk Bae, Seong Kyu Baek, Andrea Costanzi, Dario Maggioni, Gyung Mo Son, Andrea Scala, Timothy Rockall
    Diseases of the Colon & Rectum.2020; 63(12): 1593.     CrossRef
  • Short- and long-term outcomes after transverse versus extended colectomy for transverse colon cancer. A systematic review and meta-analysis
    Marco Milone, Michele Manigrasso, Ugo Elmore, Francesco Maione, Nicola Gennarelli, Fabio Rondelli, Nunzio Velotti, Giovanni Domenico De Palma
    International Journal of Colorectal Disease.2019; 34(2): 201.     CrossRef
  • Non-anatomical colonic resections: splenic flexure and transverse colectomy. Central vascular ligation is crucial for survival
    Rossella Reddavid, Laura Esposito, Andrea Evangelista, Silvia Sofia, Maurizio Degiuli
    Minerva Chirurgica.2019;[Epub]     CrossRef
  • Is Segmental Colon Resection an Alternative Treatment for Splenic Flexure Cancer?
    Refik Bademci, Jesus Bollo, C. Martinez Sanchez, Pilar Hernadez, Eduardo Maria Targarona
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2019; 29(5): 621.     CrossRef
  • Laparoscopic resection of splenic flexure colon cancer – a video vignette
    G. Lisi, G. M. Garbarino, R. Del Giudice, D. Spoletini, M. Carlini
    Colorectal Disease.2019; 21(9): 1090.     CrossRef
  • Treatment of splenic flexure colon cancer: a comparison of three different surgical procedures: Experience of a high volume cancer center
    Daniela Rega, Ugo Pace, Dario Scala, Paolo Chiodini, Vincenza Granata, Andrea Fares Bucci, Biagio Pecori, Paolo Delrio
    Scientific Reports.2019;[Epub]     CrossRef
  • Intracorporeal Versus Extracorporeal Anastomosis for Laparoscopic Resection of the Splenic Flexure Colon Cancer: A Multicenter Propensity Score Analysis
    Michele Grieco, Diletta Cassini, Domenico Spoletini, Enrica Soligo, Emanuela Grattarola, Gianandrea Baldazzi, Silvio Testa, Massimo Carlini
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2019; 29(6): 483.     CrossRef
  • Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer
    Yang Xi, Pan Yuefen, Wu Wei, Qi Quan, Zhuang Jing, Xu Jiamin, Han Shuwen
    Journal of Translational Medicine.2019;[Epub]     CrossRef
  • Subtotal colectomy versus left hemicolectomy for the elective treatment of splenic flexure colonic neoplasia
    Marc Beisani, Francesc Vallribera, Albert García, Laura Mora, Sebastiano Biondo, Jaime Lopez-Borao, Ramon Farrés, Júlia Gil, Eloy Espin
    The American Journal of Surgery.2018; 216(2): 251.     CrossRef
  • Lymphatic Drainage of the Splenic Flexure Defined by Intraoperative Scintigraphic Mapping
    Carolyn E. Vasey, Siraj Rajaratnam, Gregory O’Grady, Mike Hulme-Moir
    Diseases of the Colon & Rectum.2018; 61(4): 441.     CrossRef
  • Robotic left colectomy with complete mesocolectomy for splenic flexure and descending colon cancer, compared with a laparoscopic procedure
    Jin Cheon Kim, Jong Lyul Lee, Yong Sik Yoon, Chan Wook Kim, In Ja Park, Seok‐Byeong Lim
    The International Journal of Medical Robotics and Computer Assisted Surgery.2018;[Epub]     CrossRef
  • Propensity score analysis of postoperative and oncological outcomes after surgical treatment for splenic flexure colon cancer
    J. Martín Arévalo, D. Moro-Valdezate, S. A. García-Botello, V. Pla-Martí, M. Garcés-Albir, L. Pérez Santiago, A. Vargas-Durán, A. Espí-Macías
    International Journal of Colorectal Disease.2018; 33(9): 1201.     CrossRef
  • How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer
    Paolo Panaccio, Tommaso Grottola, Marco Ricciardiello, Pierluigi di Sebastiano, F. Francesco di Mola
    Langenbeck's Archives of Surgery.2018; 403(6): 769.     CrossRef
  • Long-term oncologic outcomes of laparoscopic surgery for splenic flexure colon cancer are comparable to conventional open surgery
    Min Ki Kim, In Kyu Lee, Won-Kyung Kang, Hyeon-Min Cho, Bong-Hyeon Kye, Heba Essam Jalloun, Jun-Gi Kim
    Annals of Surgical Treatment and Research.2017; 93(1): 35.     CrossRef
  • Surgical Treatment of Colon Cancer of the Splenic Flexure: A Systematic Review and Meta-analysis
    Aleix Martínez-Pérez, Francesco Brunetti, Giulio C. Vitali, Solafah Abdalla, Frédéric Ris, Nicola de’Angelis
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2017; 27(5): 318.     CrossRef
  • Laparoscopic extended right colectomy versus laparoscopic left colectomy for carcinoma of the splenic flexure: a matched case–control study
    Nicola de’Angelis, Elisabeth Hain, Mara Disabato, Cristiana Cordun, Maria Clotilde Carra, Daniel Azoulay, Francesco Brunetti
    International Journal of Colorectal Disease.2016; 31(3): 623.     CrossRef
  • Laparoscopic resection of splenic flexure tumors
    Massimo Carlini, Domenico Spoletini, Fabio Castaldi, Cristiano Giovannini, Umberto Passaro
    Updates in Surgery.2016; 68(1): 77.     CrossRef
  • Operative Method for Transverse Colon Carcinoma: Transverse Colectomy Versus Extended Colectomy
    Choon Seng Chong, Jung Wook Huh, Bo Young Oh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee
    Diseases of the Colon & Rectum.2016; 59(7): 630.     CrossRef
  • Optimum Level of Vessel Ligation in Splenic Flexure Cancer
    Kim Nam Kyu
    Journal of Surgery and Surgical Research.2016; : 055.     CrossRef
  • Splenic flexure colon cancers: minimally invasive treatment
    Valentino Fiscon, Giuseppe Portale, Giovanni Migliorini, Flavio Frigo
    Updates in Surgery.2015; 67(1): 55.     CrossRef
  • Laparoscopic colonic resection for splenic flexure cancer: our experience
    Andrea Pisani Ceretti, Nirvana Maroni, Matteo Sacchi, Stefano Bona, Maria Rachele Angiolini, Paolo Bianchi, Enrico Opocher, Marco Montorsi
    BMC Gastroenterology.2015;[Epub]     CrossRef
  • The short- and long-term outcomes for patients with splenic flexure tumours treated by left versus extended right colectomy are comparable: a retrospective analysis
    Manfred Odermatt, Najaf Siddiqi, Rose Johns, Danilo Miskovic, Omar Khan, Jim Khan, Amjad Parvaiz
    Surgery Today.2014; 44(11): 2045.     CrossRef
  • Elective subtotal colectomy with ileosigmoid anastomosis for colon cancer preserves bowel function and quality of life
    G. Manceau, E. d'Annunzio, M. Karoui, S. Breton, G. Rousseau, A. S. Blanchet, J. C. Vaillant, L. Hannoun
    Colorectal Disease.2013; 15(9): 1078.     CrossRef
  • Totally laparoscopic resection of the splenic flexure for tumor
    Francesco Roscio, Camillo Bertoglio, Antonio De Luca, Paolo Frattini, Federico Clerici, Ildo Scandroglio
    Updates in Surgery.2012; 64(3): 185.     CrossRef
  • Does the outcome of colonic flexure cancers differ from the other colonic sites?
    Irshad A. Shaikh, Stuart A. Suttie, Mary Urquhart, Amin I. Amin, Thomas Daniel, Satheesh Yalamarthi
    International Journal of Colorectal Disease.2012; 27(1): 89.     CrossRef
  • Colon Cancer in the Splenic Flexure
    Masayuki Nakashima, Takashi Akiyoshi, Masashi Ueno, Yosuke Fukunaga, Satoshi Nagayama, Yoshiya Fujimoto, Tsuyoshi Konishi, Rota Noaki, Keiko Yamakawa, Yasutomo Nagasue, Hiroya Kuroyanagi, Toshiharu Yamaguchi
    Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2011; 21(6): 415.     CrossRef
  • 12,666 View
  • 98 Download
  • 59 Crossref
Close layer
Wernicke's Encephalopathy in Advanced Gastric Cancer
Eun Suk Jung, Obin Kwon, Soo Hyun Lee, Ki Byung Lee, Joo Hoon Kim, Sang Hyun Yoon, Gun Min Kim, Hei-Cheul Jeung, Sun Young Rha
Cancer Res Treat. 2010;42(2):77-81.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.77
AbstractAbstract PDFPubReaderePub
Purpose

With their prolonged survival and malnutrition, cancer patients, and especially gastrointestinal (GI) tract cancer patients, can develop Wernicke's encephalopathy (WE). The aim of this study is to remind physicians of the importance of WE and prompt management in patients with GI tract cancer.

Materials and Methods

This study is a retrospective review of 2 cases of WE in advanced gastric cancer (AGC) patients, and we review the literature for cases of GI tract cancer related to WE.

Results

A 48-year-old female with AGC presented dizziness and diplopia for 5 days and a 20 kg weight loss. Neurologic exam showed nystagmus and gaze disturbance. Her symptoms improved after daily parenteral injection of thiamine 100 mg for 17 days. A 58-year-old female with AGC presented with sudden disorientation, confusion and 15 kg weight loss. Neurologic exam showed gaze limitation and mild ataxia. Despite daily parenteral injection of thiamine 100 mg for 4 days, she died 5 days after the onset of neurologic symptoms. Combining the cases noted in the literature review with our 2 cases, the 7 gastric cancer cases and 2 colorectal cancer cases related to WE showed similar clinical characteristics; 1) a history of long-period malnutrition and weight loss, 2) relatively typical neurologic signs and symptoms and 3) specific magnetic resonance image findings. Except for 2 patients who had irreversible neurologic symptoms, the other 7 patients were improved with prompt thiamine treatment.

Conclusion

It is important to consider WE in GI tract cancer patients with acute neurologic symptoms and who are in a state of malnutrition. Thiamine should be given as soon as possible when WE is suspected.

Citations

Citations to this article as recorded by  
  • Duodenal Adenocarcinoma in the Setting of Bariatric Surgery: A Perfect Storm for Wernicke’s Encephalopathy
    Aliza Gross, Allen T Yu, Jacques Lara-Reyna, Koji Park, Eugenius J Harvey
    Cureus.2023;[Epub]     CrossRef
  • Thiamine deficiency in pregnancy and lactation: implications and present perspectives
    Ozaifa Kareem, Sobia Nisar, Masood Tanvir, Umar Muzaffer, G. N. Bader
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Beware of lethal Wernicke's encephalopathy after cytoreductive surgery with HIPEC for peritoneal pseudomyxoma: Case report of morbidity and mortality review
    Oumayma Lahnaoui, Nezha EL Bahaoui, Sara El Atiq, Laila Amrani, Mohammed Anass Majbar, Amine Benkabbou, Raouf Mohsine, Amine Souadka
    International Journal of Surgery Case Reports.2022; 98: 107500.     CrossRef
  • Thiamine deficiency unrelated to alcohol consumption in high‐income countries: a literature review
    Filomena Gomes, Gilles Bergeron, Megan W. Bourassa, Philip R. Fischer
    Annals of the New York Academy of Sciences.2021; 1498(1): 46.     CrossRef
  • WERNICKE ENCEPHALOPATHY IN A PATIENT WITH GASTRIC CANCER RECURRENCE AFTER UPPER GASTROINTESTINAL SURGERY: A CASE REPORT AND REVIEW OF THE LITERATURE
    Zining Liu, Xin Ye, Jiejin Yang, Zeyang Chen
    Gastroenterology Nursing.2020; 43(6): 463.     CrossRef
  • Wernicke's encephalopathy in a subject with enter-colic fistula
    Daniele Canova, Paola Scalon, Fabio Monica, Stefano A. Grassi, Anna Giacomin, Tiziana Tumelero, Gaetano Mastropaolo, Francesco Malfa
    Gazzetta Medica Italiana Archivio per le Scienze Mediche.2019;[Epub]     CrossRef
  • Wernicke's encephalopathy in a patient with non-Hodgkin's lymphoma post-Autologous HSCT
    João Paulo de Vasconcelos Leitão, Romélia Pinheiro Gonçalves Lemes, Maritza Cavalcante Barbosa, Beatriz Stela Gomes de Souza Pitombeira Araújo, Karine Sampaio Nunes Barroso, Jacques Kaufman, Talyta Ellen de Jesus dos Santos, Anna Thawanny Gadelha Moura, A
    Revista da Associação Médica Brasileira.2018; 64(10): 882.     CrossRef
  • Wernicke encephalopathy as initial presentation of lymphoma
    Ju Hyun Seo, Ju Hee Kim, Der Sheng Sun, Hye Sung Won, Jeong Wook Park, Yoon Ho Ko
    The Korean Journal of Internal Medicine.2017; 32(6): 1112.     CrossRef
  • The Role of Thiamine and Effects of Deficiency in Dogs and Cats
    Georgia Kritikos, Jacqueline Parr, Adronie Verbrugghe
    Veterinary Sciences.2017; 4(4): 59.     CrossRef
  • Association between malignancy and non-alcoholic Wernicke's encephalopathy: a case report and literature review
    Evan Y. Choi, William A. Gomes, Missak Haigentz, Jerome J. Graber
    Neuro-Oncology Practice.2016; 3(3): 196.     CrossRef
  • Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Antonio Macrì, Francesco Fleres, Antonio Ieni, Maurizio Rossitto, Tommaso Mandolfino, Salvatore Micalizzi, Francesco Iaropoli, Carmelo Mazzeo, Massimo Trovato, Eugenio Cucinotta, Edoardo Saladino
    International Journal of Surgery Case Reports.2015; 16: 29.     CrossRef
  • Two Cases of Wernicke's Encephalopathy That Developed during Total Parenteral Nutrition in Colon Cancer Patients Treated with 5-Fluorouracil-based Chemotherapy
    Kyung Pyo Cho, Jae Sung Lee, Ji Seok Seong, Yong Moon Woo, Young Jun Cho, Beom Jin Jeong, Jee Hoon Sohn, Su-Jung Kim
    The Korean Journal of Gastroenterology.2014; 64(3): 158.     CrossRef
  • Wernicke's encephalopathy in a patient with gastric carcinoma: a diagnosis not to miss
    Chandrashekar Udyavara Kudru, Shivashankara Kaniyoor Nagiri, Sandeep Rao
    BMJ Case Reports.2014; : bcr2013203511.     CrossRef
  • Wernicke-Korsakoff Syndrome in Primary Peritoneal Cancer
    Ki Hyang Kim
    Case Reports in Oncology.2013; 6(3): 593.     CrossRef
  • 12,289 View
  • 86 Download
  • 14 Crossref
Close layer
Time-course Transcriptional Profiling of Human Amniotic Fluid-derived Stem Cells Using Microarray
Yong Wook Kim, Hyun-Jung Kim, Su-Mi Bae, Young Jae Kim, Jong-Chul Shin, Heung-Jae Chun, Jong-Won Rhie, Jiyoung Kim, Haekwon Kim, Woong Shick Ahn
Cancer Res Treat. 2010;42(2):82-94.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.82
AbstractAbstract PDFPubReaderePub
Purpose

To maintain the homeostasis of stem cells and prevent their ability to initiate tumorigenesis, it is important to identify and modify factors that prevent or accelerate stem cell senescence. We used microarrays to attempt to identify such factors in human amniotic fluid (HAF)-derived stem cells.

Materials and Methods

To identify gene expression changes over a time course, we compared gene expression profiles of HAF-derived stem cells in different passages (1st, 2nd, 4th, 6th, 8th, and 10th) using a Sentrix Human illumina microarray.

Results

Of the 25,804 genes in the microarray chip, 1,970 showed an over 2-fold change relative to the control (the 1st passage)-either upregulated or downregulated. Quantitative real-time PCR validated the microarray data for selected genes: markedly increased genes were CXCL12, cadherin 6 (CDH6), and folate receptor 3 (FOLR3). Downregulated genes included cyclin D2, keratin 8, insulin-like growth factor 2 (IGF2), natriuretic peptide precursor B (NPPB) and cellular retinoic acid binding protein 2 (CRABP2). The expression pattern of the selected genes was consistent with the microarray data except for CXCL12 and IGF2. Interestingly, the expression of NPPB was dramatically downregulated along the time course; it was almost completely shut-down by the 10th passage. In contrast, FOLR3 mRNA expression was dramatically increased.

Conclusion

Taken together, although a function for NPPB and FOLR3 in stem cell senescence has not been reported, our results strongly suggest that NPPB and/or FOLR3 play a significant role in the regulation of stem cell senescence.

Citations

Citations to this article as recorded by  
  • Recent Advances in Folates and Autoantibodies against Folate Receptors in Early Pregnancy and Miscarriage
    Xue-Yun Qin, Si-Yao Ha, Lu Chen, Tao Zhang, Ming-Qing Li
    Nutrients.2023; 15(23): 4882.     CrossRef
  • Cancer Stem Cells: Emergent Nature of Tumor Emergency
    Yaroslav R. Efremov, Anastasia S. Proskurina, Ekaterina A. Potter, Evgenia V. Dolgova, Oksana V. Efremova, Oleg S. Taranov, Aleksandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Sergey S. Bogachev
    Frontiers in Genetics.2018;[Epub]     CrossRef
  • Systematic identification of an integrative network module during senescence from time-series gene expression
    Chihyun Park, So Jeong Yun, Sung Jin Ryu, Soyoung Lee, Young-Sam Lee, Youngmi Yoon, Sang Chul Park
    BMC Systems Biology.2017;[Epub]     CrossRef
  • Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections
    Lucas-Sebastian Spitzhorn, Md Shaifur Rahman, Laura Schwindt, Huyen-Tran Ho, Wasco Wruck, Martina Bohndorf, Silke Wehrmeyer, Audrey Ncube, Ines Beyer, Carsten Hagenbeck, Percy Balan, Tanja Fehm, James Adjaye
    Stem Cells International.2017; 2017: 1.     CrossRef
  • Scavenger receptor class A member 5 ( SCARA5 ) and suprabasin ( SBSN ) are hub genes of coexpression network modules associated with peripheral vein graft patency
    Richard D. Kenagy, Mete Civelek, Shinsuke Kikuchi, Lihua Chen, Anthony Grieff, Michael Sobel, Aldons J. Lusis, Alexander W. Clowes
    Journal of Vascular Surgery.2016; 64(1): 202.     CrossRef
  • Amniotic Fluid-Derived Stem Cells (AFSC) and Their Application in Cell Therapy and Tissue Engineering
    Syeda Zahra Anum, Seyed Raheel Muzavir, Ahmad Hassan, Amir Ali Khan, Aftab Ahmad
    Razavi International Journal of Medicine.2015;[Epub]     CrossRef
  • Simvastatin Modulates Mesenchymal Stromal Cell Proliferation and Gene Expression
    Dalila Lucíola Zanette, Julio Cesar Cetrulo Lorenzi, Rodrigo Alexandre Panepucci, Patricia Vianna Bonini Palma, Daiane Fernanda dos Santos, Karen Lima Prata, Wilson Araújo Silva, Benedetta Bussolati
    PLOS ONE.2015; 10(4): e0120137.     CrossRef
  • Senescence and longevity in amniotic fluid derived cells
    Z. Chen, A. Jadhav, F. Wang, M. Perle, R. Basch, B. K. Young
    Stem Cell Discovery.2013; 03(01): 47.     CrossRef
  • Amniotic Fluid and Amniotic Membrane Stem Cells: Marker Discovery
    Maria G. Roubelakis, Ourania Trohatou, Nicholas P. Anagnou
    Stem Cells International.2012; 2012: 1.     CrossRef
  • Applications of Amniotic Membrane and Fluid in Stem Cell Biology and Regenerative Medicine
    Kerry Rennie, Andrée Gruslin, Markus Hengstschläger, Duanqing Pei, Jinglei Cai, Toshio Nikaido, Mahmud Bani-Yaghoub
    Stem Cells International.2012; 2012: 1.     CrossRef
  • 12,783 View
  • 63 Download
  • 10 Crossref
Close layer
Role of Loss of O6-Methylguanine DNA Methyltransferase (MGMT) Expression in Non-Small Cell Lung Carcinomas (NSCLCs): with Reference to the Relationship with p53 Overexpression
Na-Hye Myong
Cancer Res Treat. 2010;42(2):95-100.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.95
AbstractAbstract PDFPubReaderePub
Purpose

Functional inactivation of the O6-methylguanine-DNA methyltransferase (MGMT) gene has been demonstrated as loss of MGMT protein and suggested that it plays an important role in primary human neoplasia, including lung cancer. It has also been reported to be associated with the G : C→A : T transition mutation in the p53 gene of lung cancer. The aims of this study were to investigate the role of MGMT expression loss and its prognostic significance in non-small cell lung carcinomas (NSCLCs), and its correlation with p53 overexpression as well as influence on patient survival.

Materials and Methods

112 surgically resected NSCLC specimens were reviewed by medical records for their clinicopathologic variables. Their tissue microarray blocks were immunostained with anti-human MGMT and p53 primary antibodies. Correlation between MGMT loss and the clinicopathologic prognostic factors, including p53 overexpression and the single or combined actions of MGMT loss and p53 overexpression on patient survival were statistically analyzed by SPSS15.0.

Results

Reduced or absent MGMT expression was found in 48 of 112 NSCLCs (43%), and significantly associated with nodal metastasis and squamous or undifferentiated cell types. Loss of MGMT expression was correlated with p53 overexpression in adenocarcinomas, but not in overall NSCLCs. Its solitary or combined actions with p53 overexpression did not have influence on patient survival.

Conclusion

Loss of MGMT expression is a relatively common event in NSCLCs and significantly associated with nodal metastasis and p53 overexpression, suggesting that it may play a major role in pulmonary carcinogenesis, and also in disease progression of NSCLCs.

Citations

Citations to this article as recorded by  
  • O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
    Birgitta I. Hiddinga, Patrick Pauwels, Annelies Janssens, Jan P. van Meerbeeck
    Lung Cancer.2017; 107: 91.     CrossRef
  • Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX
    Carole Vitellius, Caroline Eymerit-Morin, Dominique Luet, Lionel Fizanne, Fanny Foubert, Sandrine Bertrais, Marie-Christine Rousselet, François-Xavier Caroli-Bosc
    Clinical Drug Investigation.2017; 37(7): 669.     CrossRef
  • Expression profiling of O6 methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases
    Xiao-Bing Jiang, Bin Hu, Dong-Sheng He, Zhi-Gang Mao, Xin Wang, Bing-Bing Song, Yong-Hong Zhu, Hai-Jun Wang
    BMC Cancer.2015;[Epub]     CrossRef
  • Bayesian inference supports a location and neighbour-dependent model of DNA methylation propagation at the MGMT gene promoter in lung tumours
    Nicolas Bonello, James Sampson, John Burn, Ian J. Wilson, Gail McGrown, Geoff P. Margison, Mary Thorncroft, Philip Crossbie, Andrew C. Povey, Mauro Santibanez-Koref, Kevin Walters
    Journal of Theoretical Biology.2013; 336: 87.     CrossRef
  • Immunohistochemical Assessment of O6-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers
    Kyung Eun Lee
    Journal of Cancer Prevention.2013; 18(4): 351.     CrossRef
  • 8,856 View
  • 37 Download
  • 5 Crossref
Close layer
Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy
Jina Yun, Kyoung-Mee Kim, Seung Tae Kim, Jung-Hoon Kim, Jung A Kim, Jee Hyun Kong, Soo Hyeon Lee, Young-Woong Won, Jong-Mu Sun, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Cancer Res Treat. 2010;42(2):101-106.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.101
AbstractAbstract PDFPubReaderePub
Purpose

The aim of this study was to determine whether the ERCC1 expression is effective to predict the clinical outcomes of patients with advanced gastric cancer (AGC) and who were treated with cisplatin-based first-line chemotherapy.

Materials and Methods

A total of 89 measurable AGC patients received cisplatin and capecitabine, with or without epirubicin, as a part of a randomized phase II study. Patients were included for the current molecular analysis if they had received two or more cycles of chemotherapy, their objective tumor responses were measured and if their paraffin-embedded tumor samples were available. The ERCC1 expression was examined by performing immunohistochemical (IHC) staining, and the patients were divided into two groups (positive or negative) according to the presence of IHC staining of the tumor cell nuclei.

Results

Of the 32 eligible patients, 21 patients (66%) had tumor with a positive expression of ERCC1 and the remaining 11 patients had tumor with a negative ERCC1-expression. The ERCC1-negative patients achieved a higher response rate than that of the ERCC1-positive patients (44% vs. 28%, respectively), although the difference was not statistically significant (p=0.42). The median survival time for the all patients was 14.6 months (95% CI: 13.6 to 15.6 months). The one-year survival rate was similar for the ERCC1-negative patients (61%) and the ERCC1-positive patients (70%).

Conclusion

In the current study, the tumor ERCC1 expression by IHC staining could not predict the clinical response or survival of AGC patients who were treated with cisplatin-based first-line chemotherapy. The ERCC1 protein expression does not appear to be a useful tool for the selection of tailored chemotherapy for these patients.

Citations

Citations to this article as recorded by  
  • Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review
    Eduardo Henrique Cunha Neves Filho, Rosane Oliveira de Sant'Ana, Luiz Vianney Saldanha Cidrão Nunes, Adriana Pinheiro Bezerra Pires, Maria do Perpétuo Socorro Saldanha da Cunha
    APMIS.2017; 125(2): 79.     CrossRef
  • Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine
    Shalong Wang, Lianwen Yuan
    BioScience Trends.2016; 10(3): 171.     CrossRef
  • Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
    Zheng-mao Lu, Tian-hang Luo, Ming-ming Nie, Guo-en Fang, Li-ye Ma, Xu-chao Xue, Guo Wei, Chong-we Ke, Jian-wei Bi
    Tumor Biology.2014; 35(4): 2941.     CrossRef
  • The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
    Kong-Kong Wei, Lei Jiang, Yao-Yao Wei, Yu-Feng Wang, Xuan-Kun Qian, Qiang Dai, Quan-Lin Guan
    Tumor Biology.2014; 35(9): 8721.     CrossRef
  • Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis
    Anqi Yao, You Wang, Xiaohong Peng, Rong Ye, Qiaoli Wang, Yuexiao Qi, Fuxiang Zhou
    Journal of Cancer Research and Clinical Oncology.2014; 140(12): 2107.     CrossRef
  • Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term
    Liqi Chen, Guoli Li, Jieshou Li, Chaogang Fan, Jian Xu, Bo Wu, Kun Liu, Caihua Zhang
    Cancer Chemotherapy and Pharmacology.2013; 71(4): 921.     CrossRef
  • ERCC1 C19007T polymorphism and the risk and invasiveness of cervical cancer in Korean women
    Seung‐Su HAN, Jae Weon KIM, Sang Hoon LEE, Dong Ho KIM, Noh‐Hyun PARK, Yong‐Sang SONG, Soon‐Beom KANG
    Asia-Pacific Journal of Clinical Oncology.2012;[Epub]     CrossRef
  • Gastric Cancer
    Joshua D. Lawson, Jason K. Sicklick, Paul T. Fanta
    Current Problems in Cancer.2011; 35(3): 97.     CrossRef
  • 10,235 View
  • 42 Download
  • 8 Crossref
Close layer
The Keratin-14 Expression in Actinic Keratosis and Squamous Cell Carcinoma: Is This a Prognostic Factor for Tumor Progression?
Kwang Hyun Choi, Gyong Moon Kim, Si Yong Kim
Cancer Res Treat. 2010;42(2):107-114.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.107
AbstractAbstract PDFPubReaderePub
Purpose

Actinic keratosis (AK) is an incipient form of cutaneous squamous cell carcinoma (SCC). We determined if the pattern of expression of keratin-14 (K14) is a factor for tumor progression in AK and SCC.

Materials and Methods

Eighteen sections from the tissues of 16 patients were stained with anti-K14 antibody and p16INK4a. Among the 16 patients, 4 were diagnosed with both SCC and AK at the same site, but AK developed first and SCC developed subsequently. Thus, SCC may have evolved from AK. The other 12 patients were only diagnosed with AK.

Results

In all of the AK and SCC tissues, basement membranes showed positive staining for K14. However, strong reactivities were shown in the spinous and granular layers and focuses of dermal invasion in the SCC tissues developed from AK. Two and 3 of the 12 AK cases had moderately positive reactions for K14 in the spinous and granular layers, respectively. Also, all SCC tissues except one had moderate-to-strong reactions in the basal, spinous, and granular layers for p16INK4a. Two of the 12 AK cases had weak-to-moderate positive reactions in the basal, spinous, and horny layers for p16INK4a.

Conclusion

The results of our study advance our understanding of the pathogenesis of SCC developing from AK. The results also indicate a differential role in the control of K14 in normal epithelia, AK, and SCC. K14 expression in the spinous and granular layers may be a prognostic factor for tumor progression of AK.

Citations

Citations to this article as recorded by  
  • Ex Vivo Analysis of Cell Differentiation, Oxidative Stress, Inflammation, and DNA Damage on Cutaneous Field Cancerization
    Lara Camillo, Elisa Zavattaro, Federica Veronese, Laura Cristina Gironi, Ottavio Cremona, Paola Savoia
    International Journal of Molecular Sciences.2024; 25(11): 5775.     CrossRef
  • Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test
    Sherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, Alison L Fitzgerald, Jennifer J Siegel, Sarah J Kurley, Kyle R Covington, Matthew S Goldberg, Aaron S Farberg, Shannon C Trotter, Kenneth Reed, David G Brodland, Shlomo A Koyfman, Ally-Khan Somani, Sarah T
    Future Oncology.2022; 18(7): 833.     CrossRef
  • Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma
    Ashley Wysong, Jason G. Newman, Kyle R. Covington, Sarah J. Kurley, Sherrif F. Ibrahim, Aaron S. Farberg, Anna Bar, Nathan J. Cleaver, Ally-Khan Somani, David Panther, David G. Brodland, John Zitelli, Jennifer Toyohara, Ian A. Maher, Yang Xia, Kristin Bib
    Journal of the American Academy of Dermatology.2021; 84(2): 361.     CrossRef
  • Expression Profile of Fibroblast Growth Factor Receptors, Keratinocyte Differentiation Markers, and Epithelial Mesenchymal Transition-Related Genes in Actinic Keratosis: A Possible Predictive Factor for Malignant Progression?
    Flavia Persechino, Danilo Ranieri, Luisa Guttieri, Monica Nanni, Maria Rosaria Torrisi, Francesca Belleudi
    Biology.2021; 10(4): 331.     CrossRef
  • Increased Expression of Flightless I in Cutaneous Squamous Cell Carcinoma Affects Wnt/β-Catenin Signaling Pathway
    Gink N. Yang, Xanthe L. Strudwick, Claudine S. Bonder, Zlatko Kopecki, Allison J. Cowin
    International Journal of Molecular Sciences.2021; 22(24): 13203.     CrossRef
  • Equine Hoof Canker: Bovine Papillomavirus Infection Is Not Associated With Impaired Keratinocyte Differentiation
    Veronika Apprich, Theresia Licka, Sabrina Freiler, Cordula Gabriel
    Veterinary Pathology.2020; 57(4): 525.     CrossRef
  • Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation
    Shun Yao, Hsin-Yi Huang, Xiangkun Han, Yi Ye, Zhen Qin, Gaoxiang Zhao, Fuming Li, Guohong Hu, Liang Hu, Hongbin Ji
    Oncogene.2019; 38(36): 6354.     CrossRef
  • Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin
    Manuel Rodríguez-Paredes, Felix Bormann, Günter Raddatz, Julian Gutekunst, Carlota Lucena-Porcel, Florian Köhler, Elisabeth Wurzer, Katrin Schmidt, Stefan Gallinat, Horst Wenck, Joachim Röwert-Huber, Evgeniya Denisova, Lars Feuerbach, Jeongbin Park, Bened
    Nature Communications.2018;[Epub]     CrossRef
  • Phenotypic characterization of oral mucosa: what is normal?
    Jaroslav Valach, René Foltán, Marek Vlk, Pavol Szabo, Karel Smetana
    Journal of Oral Pathology & Medicine.2017; 46(9): 834.     CrossRef
  • A Mouse Model of Hyperproliferative Human Epithelium Validated by Keratin Profiling Shows an Aberrant Cytoskeletal Response to Injury
    Samal Zhussupbekova, Rohit Sinha, Paula Kuo, Paul F. Lambert, Ian H. Frazer, Zewen K. Tuong
    EBioMedicine.2016; 9: 314.     CrossRef
  • Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features
    Jason F. Solus, George F. Murphy, Stefan Kraft
    International Journal of Surgical Pathology.2016; 24(1): 29.     CrossRef
  • Coordinate expression of cytokeratins 7 and 14, vimentin, and Bcl-2 in canine cutaneous epithelial tumors and cysts
    Jason B. Pieper, Adam W. Stern, Suzette M. LeClerc, Karen L. Campbell
    Journal of Veterinary Diagnostic Investigation.2015; 27(4): 497.     CrossRef
  • The influence of the location of the lesion on the absolute risk of the development of skin cancer in a patient with actinic keratosis
    P. Smit, E. Plomp, H.A.M. Neumann, H.B. Thio
    Journal of the European Academy of Dermatology and Venereology.2013; 27(6): 667.     CrossRef
  • Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells
    Hunain Alam, Lalit Sehgal, Samrat T. Kundu, Sorab N. Dalal, Milind M. Vaidya, Robert David Goldman
    Molecular Biology of the Cell.2011; 22(21): 4068.     CrossRef
  • A new approach for skin tumor treatment: from delivery system characterization to in vivo evaluation
    Denize Ainbinder, Elka Touitou
    Drug Delivery and Translational Research.2011; 1(1): 53.     CrossRef
  • 9,247 View
  • 61 Download
  • 15 Crossref
Close layer
Case Reports
A Case of Pure Red Cell Aplasia Associated with Angioimmunoblastic T-cell Lymphoma
Jung-Hye Choi, Young-Ha Oh, Ile-Kyu Park
Cancer Res Treat. 2010;42(2):115-117.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.115
AbstractAbstract PDFPubReaderePub

Pure red cell aplasia is a bone marrow failure characterized by a progressive normocytic anemia and reticulocytopenia without leucopenia and thrombocytopenia. It is associated with various hematologic diseases. However, pure red cell aplasia with angioimmunoblastic T cell lymphoma has rarely been reported. Here we describe a 43-year-old woman with pure red cell aplasia associated with angioimmunoblastic T-cell lymphoma. She had severe anemia (hemoglobin 6.9 g/dL) and a low reticulocyte count (0.2%). Direct and indirect Coombs' tests were positive. A CT scan of the abdomen revealed marked hepatosplenomegaly and small multiple lymphadenopathies. A bone marrow biopsy revealed focal infiltration of abnormal lymphoid cells and absence of red cell precursors. Splenic biopsy was compatible with angioimmunoblastic T-cell lymphoma. Ultimately, diagnosis of pure red cell aplasia associated with angioimmunoblastic T-cell lymphoma was made. After initiating CHOP therapy, the patient achieved complete remission, which was accompanied, shortly thereafter, by a rise in hemoglobin levels which finally returned to normal.

Citations

Citations to this article as recorded by  
  • Sequential Complications of Hypercalcemia, Necrotizing Granulomatous Vasculitis, and Aplastic Anemia Occurring in One Patient with Angioimmunoblastic T-cell Lymphoma
    Sriman Swarup, Jonathan Kopel, Kyaw Zin Thein, Kaiser Tarafdar, Khatrina Swarup, Seshadri Thirumala, Donald P. Quick
    The American Journal of the Medical Sciences.2021; 361(3): 375.     CrossRef
  • Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report
    Teiko Kawahigashi, Izumi Kitagawa, Eri Tanaka
    World Journal of Clinical Oncology.2020; 11(6): 405.     CrossRef
  • EXPERIENCE OF MANAGING ANEMIA IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
    Hiromi Hashimoto, Shinya Ohata, Takako Tomita, Kazuko Konishi, Yoshinori Kubota, Maki Kanzawa, Yosuke Minami, Takeshi Sugimoto
    Japanese Journal of Transfusion and Cell Therapy.2017; 63(1): 30.     CrossRef
  • Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile
    Timothy Beer, Patrick Dorion
    Hematology Reports.2015; 7(2): 5893.     CrossRef
  • B-Cell Prolymphocytic Leukemia Carrying t(8;14)(q24;q32), Associated with Both Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia
    Futoshi Iioka, Takashi Akasaka, Masahiko Hayashida, Atsuko Okumura, Hitoshi Ohno
    Journal of Clinical and Experimental Hematopathology.2014; 54(3): 219.     CrossRef
  • Angioimmunoblastic T-cell lymphoma-associated pure red cell aplasia with abdominal pain
    Jin Tao
    World Journal of Clinical Oncology.2013; 4(3): 75.     CrossRef
  • Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
    Efthymia Vlachaki, Michael D. Diamantidis, Philippos Klonizakis, Styliani Haralambidou-Vranitsa, Elizabeth Ioannidou-Papagiannaki, Ioannis Klonizakis
    The Scientific World Journal.2012; 2012: 1.     CrossRef
  • 9,868 View
  • 59 Download
  • 7 Crossref
Close layer
A Case of 5-Fluorouracil Induced Encephalopathy
Kyung A Kwon, Hyuk-Chan Kwon, Min Chan Kim, Sung-Hyun Kim, Sung Yong Oh, Suee Lee, Hyo-Jin Kim
Cancer Res Treat. 2010;42(2):118-120.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.118
AbstractAbstract PDFPubReaderePub

Patients with reduced dihydropyrimidine dehydrogenase (DPD) activity are at risk for experiencing serious adverse effects following 5-fluorouracil (5-FU) based chemotherapy. Neurotoxicity is considered an extremely rare side effect of 5-FU. We report here on an unusual case of 5-FU induced encephalopathy. A 38-year-old woman with advanced gastric carcinoma was treated with adjuvant chemotherapy that consisted of infused 5-FU (1,000 mg/m2) for 5 days and cisplatin (60 mg/m2) on day 1 following total gastrectomy. Nineteen days after starting chemotherapy, the patient displayed a sudden onset of slurred speech, confusion, cognitive disturbances and paranoia. A magnetic resonance image (MRI) of the brain showed no structural abnormalities, and the other laboratory tests provided no explanations for her symptoms, other than a slightly elevated ammonia level. The patient was treated with a lactulose retention enema and thiamine infusion, the 5-FU was halted and her symptoms then recovered after 7 days.

Citations

Citations to this article as recorded by  
  • Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
    Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, Maria de Lourdes Bastos, Susana Isabel Sá, João Paulo Capela, Félix Carvalho, Vera Marisa Costa
    Archives of Toxicology.2022; 96(1): 11.     CrossRef
  • Chemotherapy-Induced Acute Reversible Toxic Leukoencephalopathy
    A. K. Vishnu, Thara Pratap, Dhanya Jacob, Muhammed Jasim Abdul Jalal, Anupama Gopalakrishnabhakthan
    Current Medical Issues.2022; 20(3): 194.     CrossRef
  • Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation
    Hemnishil K. Marella, Rahul Peravali, Amit L. Jain, Satheesh Nair, Benedict Maliakkal, Uchenna Agbim, Rajanshu Verma
    Baylor University Medical Center Proceedings.2020; 33(2): 256.     CrossRef
  • Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies
    Claudia Pellacani, Georgios Eleftheriou
    Advances in Medical Sciences.2020; 65(2): 265.     CrossRef
  • Thiamine deficiency in the outpatient psychiatric oncology setting: A case series
    Rose Zhang, Sudhakar Tummala, Deepti Chopra
    Palliative and Supportive Care.2020; 18(5): 609.     CrossRef
  • 5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy
    Alice Boilève, Camille Wicker, Benjamin Verret, Florence Leroy, David Malka, Mathieu Jozwiak, Clément Pontoizeau, Chris Ottolenghi, Pascale De Lonlay, Michel Ducreux, Antoine Hollebecque
    Anti-Cancer Drugs.2019; 30(3): 313.     CrossRef
  • An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know
    Daniel A. Smith, Bhanusupriya Somarouthu, Nikhil H. Ramaiya
    Abdominal Radiology.2019; 44(6): 2182.     CrossRef
  • A case of acute leukoencephalopathy induced by a combination of 5-fluorouracil and metronidazole
    Tatsuya Fukumoto, Fumiaki Katada, Susumu Sato, Hidehiro Shibayama, Shigeo Murayama, Toshio Fukutake
    Rinsho Shinkeigaku.2018; 58(2): 118.     CrossRef
  • The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV/AIDS with uridine triacetate
    Cynthia Santos, Brent W. Morgan, Robert J. Geller
    The American Journal of Emergency Medicine.2017; 35(5): 802.e7.     CrossRef
  • Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach
    Michele Boisdron-Celle, Olivier Capitain, Roger Faroux, Christophe Borg, Jean Philippe Metges, Marie Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, Karine Bouhier-Leporrier, Eric Francois, Isabelle Baumgaertner, Véronique Guerin-Meyer, Oana Cojocarasu, Ce
    Seminars in Oncology.2017; 44(1): 13.     CrossRef
  • Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy
    Seiichiro Mitani, Shigenori Kadowaki, Azusa Komori, Keiji Sugiyama, Yukiya Narita, Hiroya Taniguchi, Takashi Ura, Masashi Ando, Yozo Sato, Hidekazu Yamaura, Yoshitaka Inaba, Makoto Ishihara, Tsutomu Tanaka, Masahiro Tajika, Kei Muro
    Medicine.2017; 96(22): e6874.     CrossRef
  • Chemotherapy induced stroke mimic: 5-Fluorouracil encephalopathy fulfilling criteria for tissue plasminogen activator therapy
    May Thuy Nguyen, Robyn Stoianovici, Luigi Brunetti
    The American Journal of Emergency Medicine.2017; 35(9): 1389.     CrossRef
  • Cancer screening and treatment in patients with end-stage renal disease: remaining issues in the field of onco-nephrology
    Yuichiro Kitai, Takeshi Matsubara, Taro Funakoshi, Takahiro Horimatsu, Manabu Muto, Motoko Yanagita
    Renal Replacement Therapy.2016;[Epub]     CrossRef
  • Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer
    Hasan Mutlu, Abdullah Büyükçelik, Zeki Akça, Abdülsamet Erden
    Journal of Oncology Pharmacy Practice.2015; 21(1): 72.     CrossRef
  • Subacute reversible toxic encephalopathy related to treatment with capecitabine: A case report with literature review and discussion of pathophysiology
    E. Lyros, S. Walter, I. Keller, P. Papanagiotou, K. Fassbender
    NeuroToxicology.2014; 42: 8.     CrossRef
  • Epilepsy in women with gynecologic malignancies
    Yixue Gu, Qin Yang, Xuefeng Wang
    Expert Review of Neurotherapeutics.2014; 14(5): 503.     CrossRef
  • Posterior Reversible Encephalopathy Syndrome (PRES) After Treatment With Oxaliplatin and 5-Fluorouracil
    Nicholas Truman, Daniel Nethercott
    Clinical Colorectal Cancer.2013; 12(1): 70.     CrossRef
  • 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
    Pierre-Yves Cordier, André Nau, Joseph Ciccolini, Manuela Oliver, Cédric Mercier, Bruno Lacarelle, Eric Peytel
    Cancer Chemotherapy and Pharmacology.2011; 68(3): 823.     CrossRef
  • 11,488 View
  • 97 Download
  • 18 Crossref
Close layer
Follicular Dendritic Cell Sarcoma: A Case Report and Review of the Literature
Bo Sik Choi, Jin Ho Baek, Young Min Shin, Jong Hyung Kim, Hyung Wook Kim, Soon Jung Lee, Hee Jeong Cha
Cancer Res Treat. 2010;42(2):121-124.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.121
AbstractAbstract PDFPubReaderePub

Follicular dendritic cells (FDC) are non-lymphoid, non-phagocytic accessory cells of the immune system and these cells are essential for antigen presentation and regulation of the reactions in germinal centers. Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that shows a low-to-intermediate malignant potential. The most commonly involved sites are the lymph nodes, but FDCS may also occur at a variety of extranodal sites, including the oral cavity, tonsils, gastrointestinal tract and liver. We describe here a 79-year-old woman who had FDCS with extensive lymph node involvement, dry cough, and an itching sensation. The patient improved after systemic chemotherapy.

Citations

Citations to this article as recorded by  
  • Pancreatic follicular dendritic cell sarcoma: a case report
    Jing Lou, Runyu Xia, Guoli Li, Jun Su, Hong Zheng
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Pancreatic follicular dendritic cell sarcoma: one case report and literature review
    Xiangyu Lu, Yilei Wu, Jun Gong, Xiaojiong Yu, Yu Zhang, Chong Yang
    Journal of International Medical Research.2022;[Epub]     CrossRef
  • Death within 9 months in patient with follicular dendritic cell sarcoma of spleen: A case report
    Zhao-Yang Xing
    Oncology Letters.2022;[Epub]     CrossRef
  • Nodal follicular dendritic cell sarcoma of the axilla with brachial plexus palsy
    Aftab Younus, Adrian Kelly, Patrick Lekgwara
    Interdisciplinary Neurosurgery.2020; 19: 100557.     CrossRef
  • Intra-abdominal Follicular Dendritic Cell Sarcoma (FDCS): Series of 18 cases of a rare entity from Pakistan
    Maha Zubair, Nasir Ud Din, Sidra Arshad, Khurram Minhas, Romana Idress, Zubair Ahmad
    Annals of Diagnostic Pathology.2020; 49: 151595.     CrossRef
  • Follicular dendritic cell sarcoma treated with a variety of chemotherapy
    Masaoki Sasaki, Hiroaki Izumi, Takaaki Yokoyama, Motohiro Kojima, Ako Hosono
    Hematological Oncology.2017; 35(4): 905.     CrossRef
  • High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
    Tasuku Kiyuna, Takashi Murakami, Yasunori Tome, Kei Kawaguchi, Kentaro Igarashi, Yong Zhang, Ming Zhao, Yunfeng Li, Michael Bouvet, Fuminori Kanaya, Arun Singh, Sarah Dry, Fritz C. Eilber, Robert M. Hoffman
    Oncotarget.2016; 7(22): 33046.     CrossRef
  • Follicular dendritic cell sarcoma with extensive lymph node involvement: A case report
    LI GU, CHUNHUI OUYANG, FANGGEN LU
    Oncology Letters.2015; 10(1): 399.     CrossRef
  • Clinical and pathological features of head and neck follicular dendritic cell sarcoma
    Ji Li, Min-Li Zhou, Shui-Hong Zhou
    Hematology.2015; 20(10): 571.     CrossRef
  • Follicular Dendritic Cell Sarcoma of the Tonsil
    Leandro Ribeiro, Nuno Lima, António Almeida, Artur Condé
    Acta Otorrinolaringologica (English Edition).2014; 65(3): 200.     CrossRef
  • Sarcoma de células foliculares dendríticas de la amígdala
    Leandro Ribeiro, Nuno Lima, António Almeida, Artur Condé
    Acta Otorrinolaringológica Española.2014; 65(3): 200.     CrossRef
  • Follicular Dendritic Cell Sarcoma of the Peripancreatic Lymph Node
    Minori ISHII, Minoru TAKADA, Hiroko NOGUCHI, Tomoko MITSUHASHI, Fumitaka NAKAMURA, Nobuichi KASHIMURA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(11): 3147.     CrossRef
  • Dendritic cell sarcoma: A pooled analysis including 462 cases with presentation of our case series
    Caner Saygin, Didem Uzunaslan, Mustafa Ozguroglu, Mustafa Senocak, Nukhet Tuzuner
    Critical Reviews in Oncology/Hematology.2013; 88(2): 253.     CrossRef
  • Paraneoplastic pemphigus associated with dendritic cell neoplasm and Castleman’s disease: report of a new case and review of the literature
    Bernardino Roca, Gerard Pitarch, Francisco Soler, Maria Penades, Elena Resino, Manuel Roca
    Open Medicine.2013; 8(2): 153.     CrossRef
  • Dendritic cell tumor in a salivary gland lymph node: a rare differential diagnosis of salivary gland neoplasms
    Sebastian P Schraven, Stefan K Plontke, Roland Syha, Falko Fend, Hartwig Wolburg, Patrick Adam
    Diagnostic Pathology.2011;[Epub]     CrossRef
  • Cervical Follicular Dendritic Cell Sarcoma: A Case Report and Review of the Literature
    M. Pizzi, K. Ludwig, G. Palazzolo, G. Busatto, C. Rettore, G. Altavilla
    International Journal of Immunopathology and Pharmacology.2011; 24(2): 539.     CrossRef
  • 11,642 View
  • 93 Download
  • 16 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP